Ganymede has filed a notice of an exempt offering of securities to raise $12,750,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Ganymede is raising $12,750,000.00 in new funding. Sources indicate as part of senior management Co-Founder, Nathan Clark played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Ganymede
Ganymede is the first PaaS for biotech software engineering. Quickly integrate apps, import data, or design pipelines using a powerful bio-aware low-code platform.
To learn more about Ganymede, visit http://www.ganymede.bio/
Contact:
Nathan Clark, Co-Founder
415-409-9768
SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved